• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Microbial Profile and Clinical Outcomes of Fungal Keratitis at a Single-Center Tertiary Care Hospital.一家三级医疗中心医院真菌性角膜炎的微生物学特征及临床结局
Clin Ophthalmol. 2022 Feb 11;16:389-399. doi: 10.2147/OPTH.S346227. eCollection 2022.
2
The clinical and microbiological features and outcomes of fungal keratitis over 9 years in Sydney, Australia.澳大利亚悉尼地区 9 年真菌性角膜炎的临床和微生物学特征及转归。
Mycoses. 2020 Jan;63(1):43-51. doi: 10.1111/myc.13009. Epub 2019 Oct 27.
3
Clinical and microbiological analysis of fungal keratitis in Toronto, Canada: A 20-year study.加拿大多伦多地区真菌性角膜炎的临床和微生物学分析:一项 20 年的研究。
Med Mycol. 2022 Jul 8;60(7). doi: 10.1093/mmy/myac047.
4
A 10-Year Retrospective Clinical Analysis of Fungal Keratitis in a Portuguese Tertiary Centre.葡萄牙一家三级医疗中心真菌性角膜炎的10年回顾性临床分析
Clin Ophthalmol. 2020 Nov 12;14:3833-3839. doi: 10.2147/OPTH.S268327. eCollection 2020.
5
Association between in vitro susceptibility and clinical outcomes in fungal keratitis.真菌性角膜炎的体外药敏与临床结局之间的关联。
J Ophthalmic Inflamm Infect. 2024 Sep 2;14(1):42. doi: 10.1186/s12348-024-00418-w.
6
Exogenous fungal endophthalmitis: microbiology and clinical outcomes.外源性真菌性眼内炎:微生物学与临床结局
Ophthalmology. 2008 Sep;115(9):1501-7, 1507.e1-2. doi: 10.1016/j.ophtha.2008.02.027. Epub 2008 May 16.
7
Clinical and Mycological Features of Fungal Keratitis: A Retrospective Single-Center Study (2012-2018).真菌性角膜炎的临床和真菌学特征:一项回顾性单中心研究(2012-2018 年)。
Turk J Ophthalmol. 2022 Apr 28;52(2):75-85. doi: 10.4274/tjo.galenos.2021.09515.
8
Incidence and microbiological profile of mycotic keratitis in a tertiary care eye hospital: A retrospective analysis.一家三级眼科专科医院真菌性角膜炎的发病率及微生物学特征:一项回顾性分析。
Saudi J Ophthalmol. 2012 Apr;26(2):217-21. doi: 10.1016/j.sjopt.2011.11.005. Epub 2011 Nov 28.
9
Fungal spectrum identified by a new slide culture and in vitro drug susceptibility using Etest in fungal keratitis.通过新型玻片培养鉴定真菌谱及使用Etest法检测真菌性角膜炎的体外药敏情况。
Curr Eye Res. 2005 Dec;30(12):1113-20. doi: 10.1080/02713680500423671.
10
Filamentous Fungal Keratitis in Taiwan: Based on Molecular Diagnosis.台湾丝状真菌性角膜炎:基于分子诊断
Transl Vis Sci Technol. 2020 Jul 21;9(8):32. doi: 10.1167/tvst.9.8.32. eCollection 2020 Jul.

引用本文的文献

1
Characterization of First Isolated from a Patient with Keratitis Clinical Case.从一名角膜炎临床病例患者中首次分离出的菌株的特性鉴定。
Infect Drug Resist. 2024 May 30;17:2183-2188. doi: 10.2147/IDR.S468800. eCollection 2024.

本文引用的文献

1
The global incidence and diagnosis of fungal keratitis.真菌性角膜炎的全球发病与诊断。
Lancet Infect Dis. 2021 Mar;21(3):e49-e57. doi: 10.1016/S1473-3099(20)30448-5. Epub 2020 Oct 22.
2
Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections.多烯类和唑类药物治疗眼部真菌感染的挑战。
J Ocul Pharmacol Ther. 2019 Jan/Feb;35(1):6-22. doi: 10.1089/jop.2018.0089. Epub 2018 Nov 8.
3
Altered Patterns of Fungal Keratitis at a London Ophthalmic Referral Hospital: An Eight-Year Retrospective Observational Study.伦敦一家眼科转诊医院真菌性角膜炎的变化模式:一项为期八年的回顾性观察研究。
Am J Ophthalmol. 2016 Aug;168:227-236. doi: 10.1016/j.ajo.2016.05.021. Epub 2016 Jun 7.
4
Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial.在一项随机试验中对局部用1%伏立康唑和5%那他霉素治疗真菌性角膜炎的重新评估。
Br J Ophthalmol. 2015 Sep;99(9):1190-5. doi: 10.1136/bjophthalmol-2014-306485. Epub 2015 Mar 4.
5
Current Thoughts in Fungal Keratitis: Diagnosis and Treatment.真菌性角膜炎的当前思考:诊断与治疗
Curr Fungal Infect Rep. 2013 Sep 1;7(3):209-218. doi: 10.1007/s12281-013-0150-110.1007/s12281-013-0150-1.
6
Differences in clinical outcomes in keratitis due to fungus and bacteria.真菌性角膜炎与细菌性角膜炎临床结局的差异。
JAMA Ophthalmol. 2013 Aug;131(8):1088-9. doi: 10.1001/jamaophthalmol.2013.1612.
7
The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.真菌性溃疡治疗试验:一项比较那他霉素与伏立康唑的随机试验。
JAMA Ophthalmol. 2013 Apr;131(4):422-9. doi: 10.1001/jamaophthalmol.2013.1497.
8
Geographic variations in microbial keratitis: an analysis of the peer-reviewed literature.微生物角膜炎的地域差异:文献综述分析。
Br J Ophthalmol. 2011 Jun;95(6):762-7. doi: 10.1136/bjo.2009.169607. Epub 2011 Apr 8.
9
Clinical and microbiological characteristics of fungal keratitis in the United States, 2001-2007: a multicenter study.2001-2007 年美国真菌性角膜炎的临床和微生物学特征:一项多中心研究。
Ophthalmology. 2011 May;118(5):920-6. doi: 10.1016/j.ophtha.2010.09.011. Epub 2011 Feb 4.
10
Comparison of natamycin and voriconazole for the treatment of fungal keratitis.那他霉素与伏立康唑治疗真菌性角膜炎的比较。
Arch Ophthalmol. 2010 Jun;128(6):672-8. doi: 10.1001/archophthalmol.2010.102.

一家三级医疗中心医院真菌性角膜炎的微生物学特征及临床结局

Microbial Profile and Clinical Outcomes of Fungal Keratitis at a Single-Center Tertiary Care Hospital.

作者信息

Menard Maylander, Shah Yesha S, Stroh Inna G, Zafar Sidra, Sriparna Manjari, Zhang Nancy, Agarwal Ank A, Shekhawat Nakul, Srikumaran Divya, Woreta Fasika

机构信息

School of Medicine, Meharry Medical College, Nashville, TN, USA.

Division of Cornea and External Disease, Department of Ophthalmology, The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

Clin Ophthalmol. 2022 Feb 11;16:389-399. doi: 10.2147/OPTH.S346227. eCollection 2022.

DOI:10.2147/OPTH.S346227
PMID:35177897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8846617/
Abstract

PURPOSE

To evaluate baseline characteristics, microbiological spectrum, management, and outcomes of patients with culture-proven fungal keratitis.

METHODS

Retrospective review of all patients with culture-proven fungal keratitis seen over 6 years at a tertiary referral center.

RESULTS

The present study included 62 eyes from 62 patients. Infection with filamentous organisms was more common than with yeast (66.1% vs 27.4%). The most common filamentous organisms were (17.7%) and (16.1%), while the most common yeast was (24.2%). The main predisposing factor for filamentous keratitis was contact lens use. Yeast keratitis is most associated with an immunocompromised host and ocular surface disease. Corneal perforation (20.0%) and surgical interventions (46.8%) were common, with 27.4% of eyes requiring at least one penetrating keratoplasty. Filamentous keratitis is more likely than yeast keratitis to require urgent penetrating keratoplasty or enucleation and to receive more than one topical and systemic antifungal agent. Visual outcomes were poor with nearly half of the eyes remaining at 20/200 or worse upon resolution of infection. Worse visual outcomes were associated with poor vision at presentation and a history of ocular surface disease. Antifungal susceptibility testing was not routinely performed, but it demonstrated a relatively high minimum inhibitory concentration for at least one antifungal drug in 90% of cases when performed (16.1%) and guided the direction of treatment for 80% of the cases.

CONCLUSION

Fungal keratitis is visually devastating. Infections with filamentous fungi predominated over yeast and were generally treated more aggressively both medically and surgically. Filamentous and yeast keratitis had similar durations of infections and visual outcomes. Antifungal susceptibility testing influenced treatment in 80% of cases in which it was performed.

摘要

目的

评估经培养证实的真菌性角膜炎患者的基线特征、微生物谱、治疗及预后。

方法

对一家三级转诊中心6年间所有经培养证实的真菌性角膜炎患者进行回顾性研究。

结果

本研究纳入了62例患者的62只眼。丝状菌感染比酵母菌感染更常见(66.1%对27.4%)。最常见的丝状菌是[具体丝状菌1](17.7%)和[具体丝状菌2](16.1%),而最常见的酵母菌是[具体酵母菌](24.2%)。丝状角膜炎的主要诱发因素是佩戴隐形眼镜。酵母菌性角膜炎最常与免疫功能低下宿主及眼表疾病相关。角膜穿孔(20.0%)和手术干预(46.8%)很常见,27.4%的眼睛至少需要进行一次穿透性角膜移植术。丝状角膜炎比酵母菌性角膜炎更有可能需要紧急穿透性角膜移植术或眼球摘除术,且接受不止一种局部和全身抗真菌药物治疗。视力预后较差,近一半的眼睛在感染消退后视力仍保持在20/200或更差。较差的视力预后与就诊时视力差及眼表疾病史相关。抗真菌药敏试验未常规进行,但在进行试验的病例中(16.1%),90%的病例显示至少一种抗真菌药物的最低抑菌浓度相对较高,并为80%的病例指导了治疗方向。

结论

真菌性角膜炎对视力有严重破坏。丝状真菌感染比酵母菌感染更为常见,在药物和手术治疗上通常更为积极。丝状和酵母菌性角膜炎的感染持续时间和视力预后相似。抗真菌药敏试验在80%进行试验的病例中影响了治疗。